Related Experiment Video
Updated: Feb 3, 2026

Technique for Isolation and Culture of Rat Jaw Bone Marrow Mesenchymal Stem Cells
Published on: May 31, 2024
MicroRNA-615-3p promotes the osteoarthritis progression by inhibiting chondrogenic differentiation of bone marrow
1Department of Orthopedics, The First People's Hospital of Wujiang District, Suzhou, China. 180809972@qq.com.
Objective:
To investigate whether microRNA-615-3p participates in the development and progression of osteoarthritis by regulating chondrogenic differentiation of bone marrow mesenchymal stem cells.
Materials And Methods:
Bone marrow mesenchymal stem cells (BMSCs) were isolated from rat bone marrow and identified by flow cytometry. After chondrogenic differentiation was induced in BMSCs, expression levels of chondrogenic-specific genes were then detected by quantitate Real-time polymerase chain reaction (qRT-PCR). Expression levels of inflammatory cytokines were detected by enzyme-linked immunosorbent assay (ELISA). Protein expression of SOX9 after overexpression or knockdown of microRNA-615-3p was detected by Western blot, respectively.
Results:
MicroRNA-615-3p was down-regulated in the process of chondrogenic differentiation of BMSCs. The mRNA expressions of chondrogenic-specific markers, COL2A1, COL10A1, ACAN and MATN3 were decreased after microRNA-615-3p overexpression in BMSCs. Overexpressed microRNA-615-3p down-regulated protein expression of SOX9. Expression levels of inflammatory cytokines, including interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin-α (IL-α) were increased after overexpression of microRNA-615-3p, while inhibition of microRNA-615-3p expression obtained the opposite result. In addition, overexpression of SOX9 rescued the effect induced by microRNA-615-3p on inflammatory cytokines.
Conclusions:
MicroRNA-615-3p participates in the development and progression of osteoarthritis by increasing the expressions of inflammatory cytokines and inhibiting chondrogenic differentiation of BMSCs.
Insights
MicroRNA-615-3p is down-regulated in osteoarthritis, inhibiting stem cell differentiation and increasing inflammation. Its regulation is crucial for osteoarthritis progression and potential therapeutic strategies.
Area of Science:
- Biochemistry
- Cell Biology
- Regenerative Medicine
Background:
- Osteoarthritis (OA) is a degenerative joint disease.
- Mesenchymal stem cells (MSCs) play a role in cartilage repair.
- MicroRNAs are key regulators of cellular processes.
Purpose of the Study:
- To investigate the role of microRNA-615-3p in osteoarthritis.
- To determine if microRNA-615-3p regulates chondrogenic differentiation of bone marrow mesenchymal stem cells (BMSCs).
Main Methods:
- Isolation and identification of rat BMSCs.
- Induction of chondrogenic differentiation.
- Quantification of gene and protein expression using qRT-PCR, ELISA, and Western blot.
- Overexpression and knockdown of microRNA-615-3p and SOX9.
Main Results:
- MicroRNA-615-3p expression decreased during BMSC chondrogenesis.
- Overexpression of microRNA-615-3p reduced chondrogenic markers and SOX9 protein.
- Increased inflammatory cytokines (IL-1, IL-6, IL-α) with microRNA-615-3p overexpression.
- SOX9 overexpression reversed the inflammatory effects of microRNA-615-3p.
Conclusions:
- MicroRNA-615-3p is involved in osteoarthritis development and progression.
- It inhibits BMSC chondrogenic differentiation and promotes inflammation.
- MicroRNA-615-3p represents a potential therapeutic target for osteoarthritis.
Related Concept Videos
Mesenchymal Stem Cells
MicroRNAs
MicroRNAs
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The Eukaryotic Promoter Region
Adult Stem Cells

